WallStreetZenWallStreetZen
Analyst Ranking
Top 4%
#167 out of 4603 analysts
Average Return
+17.41%
Win Rate
55%70 out of 128
Risk vs Reward
Poor
Good

Vamil Divan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cabaletta Bio IncCABA
+702.34%$1.28$10.27
2022-05-25 -
2023-05-24
Strong Buy
Cabaletta Bio IncCABA
+313.27%$1.96$8.10
2022-03-18 -
2023-03-17
Strong Buy
Insmed IncINSM
+213.95%$20.36$63.92
2023-07-26 -
2024-06-14
Strong Buy
Revance Therapeutics IncRVNC
+170.20%$13.22$35.72
2022-05-11 -
2023-05-11
Strong Buy
Insmed IncINSM
+142.40%$26.37$63.92
2023-09-05 -
2024-06-14
Strong Buy

Vamil Divan Analyst Color

Get additional color on Vamil Divan's coverage of popular stocks

Vamil Divan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Revance Therapeutics IncRVNC
5Hold$8.00+183.69%Maintains
a month ago
Ani Pharmaceuticals IncANIP
8Strong Buy$77.00+22.96%Reiterates
2 months ago
Alpine Immune Sciences IncALPN
1Strong Buy$55.00-15.35%Initiates Coverage On
2 months ago
Vera Therapeutics IncVERA
3Strong Buy$56.00+55.47%Reiterates
2 months ago
Abbvie IncABBV
16Strong Buy$190.00+12.70%Maintains
3 months ago
Insmed IncINSM
3Strong Buy$54.00-15.52%Maintains
4 months ago
Pfizer IncPFE
12Strong Buy$36.00+30.77%Initiates Coverage On
4 months ago
Karuna Therapeutics IncKRTX
7Hold$330.00+0.05%Downgrades
5 months ago
Travere Therapeutics IncTVTX
3Strong Buy$18.00+151.05%Maintains
9 months ago
Sage Therapeutics IncSAGE
7Hold$20.00+66.67%Maintains
9 months ago
Calliditas Therapeutics AbCALT
2Hold$18.00-53.57%Maintains
10 months ago
Relmada Therapeutics IncRLMD
2Strong Buy$26.00N/AReiterates
a year ago
Chinook Therapeutics IncKDNY
3Hold$40.00N/ADowngrades
a year ago
Scynexis IncSCYX
2Strong Buy$9.00N/AMaintains
a year ago
Aerovate Therapeutics IncAVTE
1Strong Buy$36.00N/AInitiates Coverage On
a year ago
Johnson & JohnsonJNJ
6Hold$161.00N/AInitiates Coverage On
a year ago
Satsuma Pharmaceuticals IncSTSA
5Hold$2.00N/ADowngrades
2 years ago
Acadia Pharmaceuticals IncACAD
7Hold$19.00N/AMaintains
2 years ago
Neurocrine Biosciences IncNBIX
5Hold$98.00N/AMaintains
2 years ago
Alkermes PLCALKS
7Strong Buy$34.00N/AMaintains
2 years ago
Cabaletta Bio IncCABA
3Strong Buy$10.00N/AMaintains
2 years ago
Axsome Therapeutics IncAXSM
3Strong Buy$49.00N/AMaintains
2 years ago
Eli Lilly & CoLLY
12Strong Buy$356.00N/AMaintains
2 years ago
Xeris Biopharma Holdings IncXERS
1Strong Buy$6.00N/AMaintains
2 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
9Strong Buy$154.00N/AMaintains
2 years ago
Evolus IncEOLS
4Strong Buy$15.00N/AUpgrades
3 years ago
Allergan PLCAGN
9Hold$155.00N/AMaintains
5 years ago
Teva Pharmaceutical Industries LtdTEVA
10Hold$20.00N/AMaintains
5 years ago
Galapagos NvGLPG
3BuyN/AN/AUpgrades
6 years ago
Portola Pharmaceuticals IncPTLA
6Hold$30.00N/AMaintains
6 years ago
Alder Biopharmaceuticals IncALDR
2Hold$17.00N/AMaintains
6 years ago
Merck & Co IncMRK
5Buy$81.00N/AMaintains
6 years ago
Corvus Pharmaceuticals IncCRVS
3Buy$15.00N/AAssumes
6 years ago
Aimmune Therapeutics IncAIMT
3Buy$40.00N/AMaintains
6 years ago
Bristol Myers Squibb CoBMY
2Hold$61.00N/AMaintains
6 years ago
Allena Pharmaceuticals IncALNAQ
2Buy$21.00N/AMaintains
6 years ago
Esperion Therapeutics IncESPR
2Buy$103.00N/AInitiates Coverage On
6 years ago
Myokardia IncMYOK
1Buy$55.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.